Sensitization to the yeast Malassezia sympodialis is specific for extrinsic and intrinsic atopic eczema

被引:85
作者
Casagrande, Barbra Fischer
Flueckiger, Sabine
Linder, Maria T.
Johansson, Catharina
Scheynius, Annika
Crameri, Reto
Schmid-Grendelmeier, Peter
机构
[1] Allergy Unit, Dept Dermatol, Zurich, Switzerland
[2] SIAF, Dept Mol Allergol, Davos, Switzerland
[3] Karolinska Inst, Dept Med, Clin Allergy Res Unit, Stockholm, Sweden
[4] Univ Hosp, Stockholm, Sweden
关键词
D O I
10.1038/sj.jid.5700431
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
The opportunistic yeast Malassezia sympodialis belongs to the normal cutaneous flora but can also cause IgE-mediated sensitization in patients suffering from atopic eczema (AE). We investigated 706 individuals by ImmunoCAPm70 and skin-prick tests with a crude M. sympodialis extract. In AE patients, we further performed skin prick tests, atopy patch tests, ELISA, and peripheral blood mononuclear cells proliferation assays with recombinant M. sympodialis allergens (rMala s 1 and 5-9). In 52/97 patients with AE-specific IgE against M. sympodialis was detectable. Almost no reactivity to M. sympodialis was seen in patients suffering from other allergic diseases (4/571) and no reactivity at all was seen in healthy controls (0/38). Skin tests showed variable recognition patterns against the different molecular structures with a predominant sensitization to rMala s 1, 5, 6, and 9, confirmed also by specific serum IgE to these allergens. Interestingly, IgE- and T-cell-mediated reactivity against M. sympodialis was also found in patients with the intrinsic form of AE. Thus, sensitization to M. sympodialis is specific for AE patients and occurs in both the extrinsic and intrinsic variant of eczema. Recombinant yeast allergens represent a useful tool to study molecular structures and differential sensitization patterns in the pathogenesis of AE.
引用
收藏
页码:2414 / 2421
页数:8
相关论文
共 53 条
  • [11] The prevalence of Malassezia Yeasts in patients with atopic dermatitis, seborrhoeic dermatitis and healthy controls
    Falk, MHS
    Linder, MT
    Johansson, C
    Bartosik, J
    Bäck, O
    Särnhult, T
    Wahlgren, CF
    Scheynius, A
    Faergemann, J
    [J]. ACTA DERMATO-VENEREOLOGICA, 2005, 85 (01) : 17 - 23
  • [12] Flückiger S, 2002, EUR J IMMUNOL, V32, P10, DOI 10.1002/1521-4141(200201)32:1<10::AID-IMMU10>3.0.CO
  • [13] 2-I
  • [14] Malassezia sympodialis stimulation differently affects gene expression in dendritic cells from atopic dermatitis patients and healthy individuals
    Gabrielsson, S
    Buentke, E
    Liedén, A
    Schmidt, M
    D'Amato, M
    Tengvall-Linder, M
    Scheynius, A
    [J]. ACTA DERMATO-VENEREOLOGICA, 2004, 84 (05) : 339 - 345
  • [15] HANIFIN JM, 1980, ACTA DERM-VENEREOL, P44
  • [16] Ikezawa Z, 2004, EUR J DERMATOL, V14, P400
  • [17] ATOPIC-DERMATITIS OF THE FACE, SCALP, AND NECK - TYPE-I REACTION TO THE YEAST PITYROSPORUM-OVALE
    JENSENJAROLIM, E
    POULSEN, LK
    WITH, H
    KIEFFER, M
    OTTEVANGER, V
    SKOV, PS
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1992, 89 (01) : 44 - 51
  • [18] Elevated levels of IgG and IgG4 to Malassezia allergens in atopic eczema patients with IgE reactivity to Malassezia
    Johansson, C
    Linder, MT
    Aalberse, RC
    Scheynius, A
    [J]. INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2004, 135 (02) : 93 - 100
  • [19] Atopy patch test reactions to Malassezia allergens differentiate subgroups of atopic dermatitis patients
    Johansson, C
    Sandström, MH
    Bartosik, J
    Särnhult, T
    Christiansen, J
    Zargari, A
    Bäck, O
    Wahlgren, CF
    Faergemann, J
    Scheynius, A
    Linder, MT
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2003, 148 (03) : 479 - 488
  • [20] A revised nomenclature for allergy -: An EAACI position statement from the EAACI nomenclature task force
    Johansson, SGO
    Hourihane, JO
    Bousquet, J
    Bruijnzeel-Koomen, C
    Dreborg, S
    Haahtela, T
    Kowalski, ML
    Mygind, N
    Ring, J
    van Cauwenberge, P
    van Hage-Hamsten, M
    Wüthrich, B
    [J]. ALLERGY, 2001, 56 (09) : 813 - 824